Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
Recruiting · NCT03383978 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2026-04-23 | NCT03383978 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johann W. Goethe University Hospital, Department of Neurosurgery | Frankfurt | Germany | 1 |
| Johann W. Goethe University Hospital, Senckenberg Institute of Neurooncology | Frankfurt | Germany | 1 |
| Neurochirurgische Klinik, Universitätsklinikum Heidelberg | Heidelberg | Germany | 1 |
| Neurochirurgische Klinik, Universitätsmedizin Mainz | Mainz | Germany | 1 |
| Neurochirurgische Klinik, Universitätsmedizin Mannheim | Mannheim | Germany | 1 |